News FDA delays decision on abuse deterrence data on Endo painkil... Data could be used to fend off generic competition.
News Branded pharma condemns UK generic price hiking Newspaper investigation reveals small number of companies hiking the prices of generic drugs.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
